tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market
Advertisement

Arrowhead Pharmaceuticals (ARWR) Financial Statements

Compare
1,584 Followers

Arrowhead Pharmaceuticals Financial Overview

Arrowhead Pharmaceuticals's market cap is currently $5.18B. The company's EPS TTM is $-1.26; its P/E ratio is ―; Arrowhead Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History

Arrowhead Pharmaceuticals Debt to Assets

Arrowhead Pharmaceuticals Cash Flow

Arrowhead Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis